These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30884095)

  • 21. The current landscape of nucleic acid therapeutics.
    Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R
    Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
    Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy.
    Avci-Adali M; A Santos H
    Adv Drug Deliv Rev; 2022 Jun; 185():114297. PubMed ID: 35427721
    [No Abstract]   [Full Text] [Related]  

  • 25. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
    Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
    Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulating the magic bullet: barriers to clinical translation of nanoparticle cancer gene therapy.
    Hendricks WP; Yang J; Sur S; Zhou S
    Nanomedicine (Lond); 2014; 9(8):1121-4. PubMed ID: 25118704
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes.
    Ewert KK; Kotamraju VR; Majzoub RN; Steffes VM; Wonder EA; Teesalu T; Ruoslahti E; Safinya CR
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1618-1623. PubMed ID: 26874401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
    Bartlett DW; Davis ME
    Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembly of stable monomolecular nucleic acid lipid particles with a size of 30 nm.
    Rudorf S; Rädler JO
    J Am Chem Soc; 2012 Jul; 134(28):11652-8. PubMed ID: 22694262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-based nanoparticles for nucleic acid delivery.
    Li W; Szoka FC
    Pharm Res; 2007 Mar; 24(3):438-49. PubMed ID: 17252188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in nanoparticle-mediated siRNA delivery.
    Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
    Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles.
    Cao ZT; Chen ZY; Sun CY; Li HJ; Wang HX; Cheng QQ; Zuo ZQ; Wang JL; Liu YZ; Wang YC; Wang J
    Biomaterials; 2016 Jul; 94():9-19. PubMed ID: 27088406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells.
    Herrera VL; Colby AH; Ruiz-Opazo N; Coleman DG; Grinstaff MW
    Nanomedicine (Lond); 2018 Aug; 13(16):2083-2098. PubMed ID: 30204054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide Spiders: Peptide-Polymer Conjugates to Traffic Nucleic Acids.
    Kwon EJ; Ko H; Bhatia SN
    Mol Pharm; 2020 Sep; 17(9):3633-3642. PubMed ID: 32786959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
    Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
    Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids.
    Ehexige E; Ganbold T; Yu X; Han S; Baigude H
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Intracellular Localization of Cationic Lipid-Nucleic Acid Nanoparticles with Fluorescence Microscopy.
    Majzoub RN; Ewert KK; Safinya CR
    Methods Mol Biol; 2016; 1445():77-108. PubMed ID: 27436314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Mol Pharm; 2015 Dec; 12(12):4466-77. PubMed ID: 26523837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zebrafish as a model system for characterization of nanoparticles against cancer.
    Evensen L; Johansen PL; Koster G; Zhu K; Herfindal L; Speth M; Fenaroli F; Hildahl J; Bagherifam S; Tulotta C; Prasmickaite L; Mælandsmo GM; Snaar-Jagalska E; Griffiths G
    Nanoscale; 2016 Jan; 8(2):862-77. PubMed ID: 26648525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.